Palliative chemotherapy preferences and factors that influence patient choice in incurable advanced cancer

Japanese Journal of Clinical Oncology

Volumn 38, Issue 1, 2008, Pages 64-70

  Kim, Min Kyoung ^a   Lee, Jae Lyun ^b   Hyun, Myung Soo ^a   Do, Young Rok ^c   Song, Hong Suk ^c   Kim, Jong Gwang ^d   Bae, Sung Hwa ^e   Ryoo, Hun Mo ^e   Park, Keon Uk ^f   Lee, Kyung Hee ^a  

^a Yeungnam University College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

^c Keimyung University   (South Korea)

^d Kyungpook National University Hospital   (South Korea)

^e Department of Internal Medicine   (South Korea)

^f Dongguk University College of Medicine   (South Korea)

Author keywords

Clinical trial; Palliative care; Quality of life

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; DOCTOR PATIENT RELATION; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PATIENT DECISION MAKING; PREDICTION; QUALITY OF LIFE; SELF EVALUATION; STRUCTURED INTERVIEW;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHOICE BEHAVIOR; DECISION MAKING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; NEOPLASMS; PALLIATIVE CARE; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE; TERMINAL CARE;

EID: 39049119351     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hym147     Document Type: Article

References (21)

1. Koedoot CG, de Haan RJ, Stiggelbout AM, et al. Palliative chemotherapy or best supportive care? A prospectivt study explaining patients' treatment preference and choice. Br J Cancer 2003;89:2219-26.
2. Blackball LJ, Murphy ST, Frank G, Michel V, Azen S. Ethnicity and attitudes toward patient autonomy. JAMA 1995;274:820-5.
3. Yun YH, Lee CG, Kim SY, et al. The attitudes of cancer patients and their families toward the disclosure of terminal illness. J Clin Oncol 2004;22:307-14.
4. Weeks JC, Cook EF, O'Day SJ, et al. Relationship between cancer patients' predictions of prognosis and their titatment preferences. JAMA 1998;279:1709-14.
5. Eidinger RN, Schapira DV. Cancer patients' ipsight into their treatment, prognosis, and unconventional therapies. Cancer 1984;53:2736-40.
6. Mackillop WJ, Stewart WE, Ginsburg AD, Stewart SS. Cancer patients' perceptions of their disease and its treatment. Br J Cancer 1988;58:351-8.
7. Sun CC, Bbdurka DC, Donato ML, et al, Patient preferences regarding side effects of chemotherapy for ovarian cancer: Do they chqnge over time? Gynecol Oncol 2005;87:118-28.
8. Brundago MD, Davidson JR, Mackillop WJ. Trading treatment toxicity for survival in locally advanced npn-small cell lung cancer. J Clin Oncol 1997;15:330-40.
9. Silvestri G, Pritchard R, Welch HG. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: Descriptive study based on scripted interviews. BMJ 1998;317:771-5.
10. Simes RJ, Coates AS. Patient preferences for adjuvant chemotherapy of early breast cancér: How much benefit is needed? J Natl Cancer Inst Monogr. 2001;30:146-152.
11. Shin HY, Jung JY, Won YJ, Park JG. 139 KCCR-affiliated Hospitals. 2002 annual report of the Korea Central Cancer Registry: Based on registered data from 139 hospitals. Cancer Res Treat 2004;36:103-14.
12. Novack DH, Plumer R, Smith RL, et al. Changes in physicians' attitudes toward telling the cancer patient. JAMA 19179;241: 897-900.
13. Han SW, Chung HY, Han SH. A study on the attitudes toward dying patients. J Korean Neuropsychiatry Assoc 1990;29:1408-25.
14. Braddock CH III, Edwards KA, Hasenberg NK Laidley TL, Levinson W. Informed decision making in outpatient practice: Time to get back to basics. JAMA 1999;282:2313-20.
15. Gattellari M, Voigt KJ, Butow PN, Tattersall MH. When the treatment goal is not cure: Are cancer patients equipped to make informed decisions? J Clin Oncol 2002;20:503-13.
16. Koedoot CG, De Haes JC, Heisterkamp SH, Bakker PJ, De Graeff A, De Haan RJ. Palliative chemotherapy or watchful waiting? A vignettes study among oncologists. J Clin Oncol 2002;20:3658-64.
17. Cassileth BR, Zupkis RV, Sutton-Smith K, March V. Information and participation preferences among cancer patients. Ann Intern Med 1980;92:832-6.
18. Macklin R. The ethical problems with sham surgery in clinical research. N Engl J Med 1999;341:992-6.
19. Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med 1994;331:394-8.
20. Temple R, Ellenberg SS. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: Ethical and scientific issues. Ann Intern Med 2000;133:455-63.
21. Ellison NM, Chevien EM. Palliative chemotherapy. In: Berger AM, Portenoy RK, Weissman DE, editors. Principles and Practice of Palliative Care and Supportive Oncology, 2nd edn. Philadelphia: Lippincott, Williams & Wilkins 2002;698-702.